These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3286785)

  • 1. Inhibitory activity of interleukin 2-activated lymphocytes on human granulocyte precursors (CFU-g).
    Iizuka Y; Sakurai T; Horikoshi A; Ohshima T
    Int J Cell Cloning; 1988 Mar; 6(2):146-59. PubMed ID: 3286785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human granulocyte-macrophage colony formation by interleukin 2-treated lymphocytes.
    Takahashi M; Oshimi K; Saito H; Mizoguchi H
    Exp Hematol; 1988 Mar; 16(3):226-30. PubMed ID: 3257447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.
    Herrera C; García-Pérez MJ; Ramirez R; Martín C; Alvarez MA; Martinez F; Gómez P; García-Castellano JM; Torres A
    Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lymphokine-activated killer cell fraction on the development of human hematopoietic progenitor cells.
    Fujimori Y; Hara H; Nagai K
    Cancer Res; 1988 Feb; 48(3):534-8. PubMed ID: 3257166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokine-activated killer cell expansion for clinical trials of adoptive immunotherapy with interleukin-2: optimization of the culture technique.
    Favrot MC; Coze C; Combaret V; Gaspard M; Colin C; Franks C; Negrier S; Philip I; Philip T
    Mol Biother; 1990 Mar; 2(1):32-7. PubMed ID: 2185792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes.
    Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA
    Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of natural killer cells on the development of syngeneic hematopoietic progenitors.
    Holmberg LA; Miller BA; Ault KA
    J Immunol; 1984 Dec; 133(6):2933-9. PubMed ID: 6436368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of interleukin-2-stimulated lymphocytes and bispecific antibodies that efficiently lyse leukemic cells does not affect bone marrow CD34-positive stem cell function in vitro.
    Kaneko T; Fukuda J; Teramura M; Fusauchi Y; Kakui Y; Okumura K; Mizoguchi H; Oshimi K
    Bone Marrow Transplant; 1994 Aug; 14(2):213-7. PubMed ID: 7527685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study of LAK and activated NK cells affecting hematopoiesis in mice].
    Sun K; Zhang M; Tian Z
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):405-8. PubMed ID: 11721419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular interactions in hemopoiesis.
    Liu SJ; Ascensão JL; Podack E; Lin BY; Arlin Z; Lutton J; Gafney E; Baskind P; Mittelman A
    Blood Cells; 1987; 13(1-2):101-10. PubMed ID: 3117139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
    Klingemann HG; Deal H; Reid D; Eaves CJ
    Exp Hematol; 1993 Aug; 21(9):1263-70. PubMed ID: 8330650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.
    Kaufmann Y; Levanon M; Davidsohn J; Ramot B
    J Immunol; 1987 Aug; 139(3):977-82. PubMed ID: 3496395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
    Atzpodien J; Gulati SC
    Stem Cells; 1993 Nov; 11(6):511-8. PubMed ID: 8111310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW; Li F; Pettit GR; Grant S
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of LAK-mediated tumor cell killing in a plasma clot clonogenic assay.
    Dinota A; Tazzari PL; Bontadini A; Raspadori D; Tassi C; Zucchini L; Pizzuti M; Ricciuti F; Gobbi M
    Haematologica; 1990; 75(4):323-6. PubMed ID: 2276678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.